1
|
Felli E, Felli E, Muttillo EM, Memeo R, Giannelli V, Colasanti M, Pellicelli A, Diana M, Ettorre GM. Liver transplantation for sickle cell disease: a systematic review. HPB (Oxford) 2021; 23:994-999. [PMID: 33431265 DOI: 10.1016/j.hpb.2020.12.007] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/25/2020] [Accepted: 12/03/2020] [Indexed: 12/12/2022]
Abstract
BACKGROUND Sickle cell disease is a group of autosomal recessive disorders characterised by haemolytic anaemia. Liver is one of the most affected organs, ranging from liver tests alterations to acute liver failure for which liver transplantation is the only life-saving treatment. METHODS This study aims to make a systematic review of the current literature to evaluate indications, timing, and results of liver transplantation for patients affected by SCD. RESULTS Twenty-nine patients in total were reported worldwide until 2018, the average patient age is 28.7 (0.42-56), all patients have a pre-transplant diagnosis of SCD. Cirrhosis at transplantation was present in six-teen (n = 16, 55.1%) patients. In ten patients (n = 10, 34.5%), acute liver failure arises from healthy liver and presented sickle cell intrahepatic cholestasis. Eleven patients (n = 11, 39.2%) died, three (n = 3, 10.7%) in the first postoperative month, and seven (n = 7, 25%) in the first year. Mean follow-up was 27 months (range: 7-96), one-year overall survival was 48.7%. DISCUSSION Liver transplantation for SCD has been increasingly reported with encouraging results. Indications are presently reserved for acute liver failure arising both in healthy liver and end-stage liver disease.
Collapse
Affiliation(s)
- Emanuele Felli
- Department of General, Digestive, and Endocrine Surgery, University Hospital of Strasbourg, Strasbourg, France; IHU-Strasbourg, Institute of Image-Guided Surgery, Strasbourg, France; Research Institute Against Digestive Cancer (IRCAD), Strasbourg, France; Institute of Viral and Liver Disease, Inserm U1110, Strasbourg, France.
| | - Eric Felli
- IHU-Strasbourg, Institute of Image-Guided Surgery, Strasbourg, France; Research Institute Against Digestive Cancer (IRCAD), Strasbourg, France
| | - Edoardo M Muttillo
- Department of General, Digestive, and Endocrine Surgery, University Hospital of Strasbourg, Strasbourg, France; Department of Surgical Sciences, Sapienza University of Rome, Rome, Italy
| | - Riccardo Memeo
- Division of Hepato-Pancreato-Biliary Surgery, "F. Miulli" General Hospital, Acquaviva Delle Fonti, Bari, Italy; Liver Transplant Unit, Policlinico di Bari, Bari, Italy
| | - Valerio Giannelli
- San Camillo Hospital, Department of Transplantation and General Surgery, Rome, Italy
| | - Marco Colasanti
- San Camillo Hospital, Department of Transplantation and General Surgery, Rome, Italy
| | - Adriano Pellicelli
- San Camillo Hospital, Department of Transplantation and General Surgery, Rome, Italy
| | - Michele Diana
- IHU-Strasbourg, Institute of Image-Guided Surgery, Strasbourg, France; Research Institute Against Digestive Cancer (IRCAD), Strasbourg, France; ICUBE Laboratory, Photonics Instrumentation for Health, University of Strasbourg, Strasbourg, France
| | - Giuseppe M Ettorre
- San Camillo Hospital, Department of Transplantation and General Surgery, Rome, Italy
| |
Collapse
|
2
|
Levesque E, Lim C, Feray C, Salloum C, Quere A, Robin B, Merle J, Esposito F, Duvoux C, Cherqui D, Habibi A, Galacteros F, Bartolucci P, Azoulay D. Liver transplantation in patients with sickle cell disease: possible but challenging—a cohort study. Transpl Int 2020; 33:1220-1229. [DOI: 10.1111/tri.13669] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2020] [Revised: 05/04/2020] [Accepted: 05/28/2020] [Indexed: 12/25/2022]
Affiliation(s)
- Eric Levesque
- Department of Anesthesia and Surgical Intensive Care‐Liver ICU AP‐HP Henri Mondor Hospital Créteil France
- Ecole Nationale Vétérinaire d’Alfort (ENVA) Faculté de Médecine de Créteil EA Dynamyc Université Paris‐Est Créteil (UPEC) Créteil France
| | - Chetana Lim
- Department of Hepatobiliary and Pancreatic Surgery and Transplantation Assistance Publique‐Hôpitaux de Paris Pitié‐Salpêtrière Hospital Paris France
| | - Cyrille Feray
- Centre Hepato‐Biliaire AP‐HP Paul Brousse Hospital Villejuif France
| | - Chady Salloum
- Centre Hepato‐Biliaire AP‐HP Paul Brousse Hospital Villejuif France
| | - Anne‐Laure Quere
- Department of Anesthesia and Surgical Intensive Care‐Liver ICU AP‐HP Henri Mondor Hospital Créteil France
| | - Benoit Robin
- Department of Anesthesia and Surgical Intensive Care‐Liver ICU AP‐HP Henri Mondor Hospital Créteil France
| | - Jean‐Claude Merle
- Department of Anesthesia and Surgical Intensive Care‐Liver ICU AP‐HP Henri Mondor Hospital Créteil France
| | | | | | - Daniel Cherqui
- Centre Hepato‐Biliaire AP‐HP Paul Brousse Hospital Villejuif France
| | - Anoosha Habibi
- Department of Internal Medicine Sickle Cell National Referral Center AP‐HP Henri Mondor Hospital‐UPEC Créteil France
| | - Frédéric Galacteros
- Department of Internal Medicine Sickle Cell National Referral Center AP‐HP Henri Mondor Hospital‐UPEC Créteil France
| | - Pablo Bartolucci
- Department of Internal Medicine Sickle Cell National Referral Center AP‐HP Henri Mondor Hospital‐UPEC Créteil France
| | - Daniel Azoulay
- Centre Hepato‐Biliaire AP‐HP Paul Brousse Hospital Villejuif France
- Department of Hepatobiliary and Pancreatic Surgery and Transplantation Sheba Medical Center Faculty of Medicine Tel Aviv University Tel Aviv Israel
| |
Collapse
|
3
|
Toward dual hematopoietic stem-cell transplantation and solid-organ transplantation for sickle-cell disease. Blood Adv 2019. [PMID: 29535106 DOI: 10.1182/bloodadvances.2017012500] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
Sickle-cell disease (SCD) leads to recurrent vaso-occlusive crises, chronic end-organ damage, and resultant physical, psychological, and social disabilities. Although hematopoietic stem-cell transplantation (HSCT) is potentially curative for SCD, this procedure is associated with well-recognized morbidity and mortality and thus is ideally offered only to patients at high risk of significant complications. However, it is difficult to identify patients at high risk before significant complications have occurred, and once patients experience significant organ damage, they are considered poor candidates for HSCT. In turn, patients who have experienced long-term organ toxicity from SCD such as renal or liver failure may be candidates for solid-organ transplantation (SOT); however, the transplanted organs are at risk of damage by the original disease. Thus, dual HSCT and organ transplantation could simultaneously replace the failing organ and eliminate the underlying disease process. Advances in HSCT conditioning such as reduced-intensity regimens and alternative donor selection may expand both the feasibility of and potential donor pool for transplantation. This review summarizes the current state of HSCT and organ transplantation in SCD and discusses future directions and the clinical feasibility of dual HSCT/SOT.
Collapse
|
4
|
Kyriakidis I, Tragiannidis A, Gompakis N. Extrahepatic biliary atresia, liver function tests, and hemoglobin variants. Afr J Paediatr Surg 2018; 15:61-62. [PMID: 30829315 PMCID: PMC6419553 DOI: 10.4103/ajps.ajps_124_16] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Affiliation(s)
- Ioannis Kyriakidis
- 2nd Department of Pediatrics, Medical School, AHEPA University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Athanasios Tragiannidis
- 2nd Department of Pediatrics, Medical School, AHEPA University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| | - Nikolaos Gompakis
- 2nd Department of Pediatrics, Medical School, AHEPA University General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
| |
Collapse
|